Abstract
RATIONALE: Despite the many pharmaceutical treatments available, allergy patients remain dissatisfied due to deleterious side-effects and ineffective symptom relief. A new, naturally-sourced, extremophile derived, anti-allergic device, Ectoin®, was investigated in this study. The objective was to assess the relative efficacy of Ectoin® Nasal Spray and Eye Drops compared to placebo on the complex of rhinoconjuntivitis symptoms in subjects exposed to highly controlled ragweed levels in an Environmental Exposure Chamber.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
